Research
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
-
* Corresponding author: Susan F Hurley susanhurley@bainbridgeconsultants.com
Cost Effectiveness and Resource Allocation 2008, 6:12 doi:10.1186/1478-7547-6-12
No comments have yet been made on this article.